Lite Strategy Inc (LITS)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · LITS
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 341.8% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name is a smaller-cap name (higher miss base rate) and operates in a high-miss-rate industry. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 66 industry peers
LITS — capital allocation — Unregistered Sales of Equity Securities
Dated 2026-11-03
Unregistered Sales of Equity Securities. As previously reported, on July 22, 2025, Lite Strategy, Inc. (the “Company”) entered into an Advisory Agreement (the “Advisory Agreement”) with Green Dragon Investments LLC (“Green Dragon”), pursuant to which the Company agreed to pay Green Dragon an asset-based fee (the “Annual Advisory Fee”) in warrants (the “Advisory Warrants”) to purchase a number of shares of common stock, par value $0.00000002 per share, of the Company (the “Common Stock”) equal…
Why it matters: Lite Strategy invested $1 million in LitVM. A live product or named partner would show progress beyond the investment.
Supportive ifThe company or LitVM names a launch date, live Litecoin app, or signed partner for its Layer 2 network.
Worry ifA company update reports the LitVM launch is delayed, the deal is ended, or no launch date is set by the next report.
Why it matters: Option sales brought in $0.7 million since October 2025. More income would show this plan is still working.
Supportive ifThe Nov. 13 report gives new covered call proceeds above the $0.7 million reported in May.
Worry ifThe Nov. 13 report shows no added proceeds, or says the covered call program has stopped.
Why it matters: The company has repurchased 13% of its shares. More buybacks can raise the LTC backing each remaining share.
Supportive ifThe Nov. 13 report shows more shares repurchased since July 17, with LTC per share above the July 17 level.
Worry ifThe Nov. 13 report shows no added buybacks, or LTC per share below the July 17 level.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$296 on $10,000 · ±3.0% | How much price usually moves either way. |
| Bad day | $822 loss on $10,000 · 8.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $6,727 loss on $10,000 · 67.3% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.